Last reviewed · How we verify
NCT00313378
Effects of Perioperative Systemic Ketamine on Development of Long-term Neuropathic Pain After Thoracotomy.
Phase 3 trial testing Hypothetica in Partial Pneumonectomy Under Lateral or Posterolateral Thoracotomy. in 78 participants. Completed in 1 May 2008.
1 May 2008
Quick facts
| Lead sponsor | University Hospital, Clermont-Ferrand |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 78 |
| Start date | 1 April 2004 |
| Primary completion | 1 May 2008 |
| Estimated completion | 1 May 2008 |
| Sites | 1 location across France |
Drugs / interventions tested
- Hypothetica — full drug profile →
Conditions studied
- Partial Pneumonectomy Under Lateral or Posterolateral Thoracotomy. — all drugs for Partial Pneumonectomy Under Lateral or Posterolateral Thoracotomy. →
Sponsor
University Hospital, Clermont-Ferrand
Who can join
Adults 20 to 75, any sex, with Partial Pneumonectomy Under Lateral or Posterolateral Thoracotomy.. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
- Reduction of chronic pain
Sponsor's own description
Lung surgery under thoracotomy is known to induce long-term pain which can be considered as neuropathic in many patients concerned \[1,2\]. The suspected origin of neuropathy is a direct traumatism of intercostal nerve(s) \[3\]. Among the possible preventive treatments that can be administered during the initial aggression, ketamine \[4,5\] appears as the easiest to use, as it is already commonly administered intra and postoperatively for improvement of analgesia \[6\].
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The neuropathic pain: An overview of the current treatment and future therapeutic approaches.
Cavalli E, Mammana S, Nicoletti F, Bramanti P, et al · · 2019 · cited 353× · PMID 30900486 · DOI 10.1177/2058738419838383 -
NMDA receptors in clinical neurology: excitatory times ahead.
Kalia LV, Kalia SK, Salter MW. · · 2008 · cited 307× · PMID 18635022 · DOI 10.1016/s1474-4422(08)70165-0
Verify or expand the search:
- PubMed search for NCT00313378
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Clermont-Ferrand trials
Trials by the same sponsor.
- NCT07179276 — Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock · NA · recruiting
- NCT07476768 — PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study · NA · not yet recruiting
- NCT07439146 — Risk of Pneumonia in Intubated Patients in Emergency Situations · not yet recruiting
- NCT07427537 — Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients · NA · recruiting
- NCT07330856 — Evaluation of Treatments for Dry or Productive Cough · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00313378 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Clermont-Ferrand
- Last refreshed: 2 April 2013
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00313378.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing